3-hydroxybenzylhydrazine has been researched along with medetomidine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koskinen, S; Koulu, M; Pesonen, U; Scheinin, H; Scheinin, M; Virtanen, R | 1 |
1 other study(ies) available for 3-hydroxybenzylhydrazine and medetomidine
| Article | Year |
|---|---|
Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Biogenic Monoamines; Brain; Dioxanes; Hydrazines; Idazoxan; Imidazoles; Male; Medetomidine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic | 1993 |